Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Viemed Healthcare Q3 2026 Results: Net Income $4.64M, Up 32.0% YoY

Viemed Healthcare reported a 20.7% increase in revenue for the nine months ended September 30, 2026, reaching $234.2 million compared to $194.1 million in the prior year. Net income attributable to the company grew to $10.0 million for the same period, while the company maintained a strong balance sheet with $150.1 million in total shareholders' equity.

Watch the Viemed Healthcare, Inc. earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue80.771.9
Gross profit46.241.3
Profit before tax6.85.1
Net income4.63.5
EPS (diluted, $ a share)$0.11$0.09

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+32.0%
Revenue, year on year+12.2%
Gross margin57.3%
Operating margin8.6%
Source

10-Q filed with the SEC, NASDAQ: VMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Viemed Healthcare, Inc.: key numbers

Share price
$9.15Close, Nov 16
Market cap
$347M
Shares outstanding
37.89MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NECSIC 8090

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Viemed Healthcare, Inc.

All →
5:04 PM ET 8-K
Financial Results

Viemed Healthcare Financial Results

Viemed Healthcare reported record third-quarter 2026 net revenue of $80.7 million, a 12.2% year-over-year increase driven by growth in ventilator and PAP therapy patient volumes. The company raised the low end of its full-year 2026 revenue guidance to a range of $316 million to $320 million and improved its net capital expenditure outlook.

Term
Q3 2026

“Viemed delivered another record quarter, with revenue reaching $80.7 million and continued growth across our respiratory, sleep, and women's health businesses.”

Casey Hoyt, Viemed’s CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.